Asia Pacific Diagnostic Labs Market Size, Share, By Lab Type, Testing Services, Diseases, Revenue Source, and Country - Trends, Analysis, and Forecast till 2034
Diagnostic laboratory is a facility, which is equipped with reagents, apparatus for performing diagnostic test and for detecting human infection. The market is strongly influenced by the boosting healthcare industries, rapid test kits, and soaring scores of persistent conditions. Apart from these factors, escalating rates of allergic diseases also boosts the diagnostic labs market growth in Asia Pacific.
Key Benefits of Purchasing This Report
- Gain valuable insights into revenue projections for the overall market and its sub-segments, benefiting industry leaders and new entrants.
- Enhance your understanding of the competitive landscape to refine business positioning and optimize go-to-market strategies.
- Stay informed on the latest trends in the Asia Pacific Diagnostic Labs Market, including key drivers, challenges, opportunities, and barriers.
Asia Pacific Diagnostic Labs Market Report Highlights:
- The market is extrapolated to enlarge at USD 22.6 billion in 2035.
- In 2024, the Asia pacific diagnostic labs market size was worth USD 14.7 billion.
- The market is growing at a CAGR of 3.4%.
- China is the dominating region in the market.
- The COVID-19 testing segment is leading the market under testing services.
- By lab type, the hospital-based labs segment is leading the market.
- On the basis of diseases, the market is dominated by the oncology segment.
- The healthcare plan revenue source segment is holding the maximum share of the market.
Asia Pacific Diagnostic Labs Market Key Highlights:
In August 2024, Unilabs, a leading international provider of diagnostic services, and C2N Diagnostics, LLC, a specialist in advanced diagnostic solutions in the field of Alzheimer’s disease and related neurological disorders, have signed a multi-year partnership agreement. This agreement will increase the access to C2N’s Precivity portfolio of blood tests on an exclusive basis in Europe, including Norway, Switzerland, and the U.K.
In March 2024, The World Health Organization (WHO) published recommendations on the use of a new class of diagnostic technologies, including the targeted next-generation sequencing (NGS) tests for the diagnosis of drug-resistant tuberculosis (TB) in the third edition of the consolidated guidelines on tuberculosis.
Segmentation:
By Lab Type:
- Single/Independent Laboratories
- Hospital-Based Labs
- Physician Office Labs
- Others
By Testing Services:
- Physiological Function Testing
- General & Clinical Testing
- Esoteric Testing
- Specialized Testing
- Non-Invasive Testing
- COVID-19 Testing
- Others
By Diseases:
- Cardiology
- Oncology
- Neurology
- Orthopedics
- Gastroenterology
- Gynecology
- Odontology
- Others
By Revenue Source:
- Healthcare Plan
- Out-of-Pocket
- Public System
By Region:
- Asia Pacific
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia-Pacific
Asia Pacific Diagnostic Labs Market Competitive Landscape
- HEALTHIANS.COM
- Pathkind Diagnostics Pvt. Ltd.
- PATHOLOGY ASIA
- Redcliffe labs
- RELIANCE MEDLAB
- APMD
- GenePath Diagnostics
- STERLING ACCURIS WELLNESS PVT. LTD.
- METROPOLIS HEALTHCARE LIMITED
- Dr Reddys Path Labs Private Limited
Key Questions Answered in This Report
1. What was the size of the Asia Pacific Diagnostic Labs Market in 2024?
2. What is the expected growth rate of the Asia Pacific Diagnostic Labs Market during 2025-2035?
3. What are the key factors driving the Asia Pacific Diagnostic Labs Market?
4. What is the breakup of the Asia Pacific Diagnostic Labs Market based on the distribution channel?
5. What are the key regions in the Asia Pacific Diagnostic Labs Market?
6. Who are the key players/companies in the Asia Pacific Diagnostic Labs Market?
7. What are the drivers, restraints, and opportunities in the Asia Pacific Diagnostic Labs Market?